https://www.marketscreener.com/quote/stock/CATALYST-PHARMACEUTICALS--36303/news/Catalyst-Pharmaceuticals-Initiates-Rolling-NDA-Submission-for-Firdapse-for-the-Treatment-of-Lambert-20730103/?utm_source=telegram&utm_medium=social&utm_campaign=share